Advertisement

Radiation therapy in acromegaly

  • Helen A. ShihEmail author
  • Jay S. Loeffler
Article

Abstract

Radiation therapy is generally not a primary treatment modality for growth hormone-secreting pituitary adenomas. However, in patients with acromegaly refractory to medical and/or surgical interventions, radiation can offer durable tumor control and often biochemical remission. Technique of radiation therapy delivery and dose vary by adenoma size and extrasellar extension. Radiation can be delivered in a single sitting by stereotactic radiosurgery or in fractionated form of smaller doses delivered over typically 5–6 weeks in 25–30 treatments. A brief overview of forms of radiation modalities is reviewed followed by discussion of the role for radiation therapy, rationale of delivery method, and potential adverse effects.

Keywords

Radiation Radiation therapy Stereotactic radiotherapy Stereotactic radiosurgery Gamma knife Proton radiation 

References

  1. 1.
    Kooy HM, Nedzi LA, Loeffler JS, et al. Treatment planning for stereotactic radiosurgery of intra-cranial lesions. Int J Radiat Oncol Biol Phys 1991;21(3):683–93.PubMedGoogle Scholar
  2. 2.
    Yoon SC, Suh TS, Jang HS, et al. Clinical results of 24 pituitary macroadenomas with linac-based stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 1998;41(4):849–53.PubMedCrossRefGoogle Scholar
  3. 3.
    Mitsumori M, Shrieve DC, Alexander E, et al. Initial clinical results of linac-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. Int J Radiat Oncol Biol Phys 1998;42(3):573–80.PubMedCrossRefGoogle Scholar
  4. 4.
    Sheehan JP, Niranjan A, Sheehan JM, et al. Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 2005;102:678–91.PubMedGoogle Scholar
  5. 5.
    Zhang N, Pan L, Wang EM, et al. Radiosurgery for growth hormone-producing pituitary adenomas. J Neurosurg 2000;93 Suppl 3:6–9.PubMedGoogle Scholar
  6. 6.
    Castinetti F, Taieb D, Kuhn J-M, et al. Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion. J Clin Endocrinol Metab 2005;90:4483–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Kobayashi T, Mori Y, Uchiyama Y, et al. Long-term results of gamma knife surgery for growth hormone-producing pituitary adenoma: is the disease difficult to cure? J Neurosurg (Suppl) 2005;102:119–23.Google Scholar
  8. 8.
    Kong D, Lee J, Lim DH, et al. The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas. Cancer 2007;110:854–60.PubMedCrossRefGoogle Scholar
  9. 9.
    Kajiwara K, Saito K, Yoshikawa K, et al. Image-guided stereotactic radiosurgery with the CyberKnife for pituitary adenomas. Minim Invasive Neurosurg 2005;48(2):91–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Roberts BK, Ouyang DL, Lad SP, et al. Efficacy and safety of CyberKnife radiosurgery for acromegaly. Pituitary 2007;10:19–25.PubMedCrossRefGoogle Scholar
  11. 11.
    Kjellberg RN, Shintani A, Fanzt AG, et al. Proton beam therapy in acromegaly. N Engl J Med 1968;278:669–95.CrossRefGoogle Scholar
  12. 12.
    Petit JH, Biller BMK, Swearingen B, et al. Proton stereotactic radiosurgery is effective and safe in the management of persistent acromegaly. In: The Endocrine Society, 88th Annual Meeting, Boston, MA, June 24–27, 2006.Google Scholar
  13. 13.
    Biermasz NR, van Dulken H, Roelfsema F. Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly. J Clin Endocrinol Metab 2000;85:2476–82.PubMedCrossRefGoogle Scholar
  14. 14.
    Milker-Zabel S, Zabel A, Huber P, et al. Stereotactic conformal radiotherapy in patients with growth hormone-secreting pituitary adenoma. Int J Radiat Oncol Biol Phys 2004;59(4):1088–96.PubMedCrossRefGoogle Scholar
  15. 15.
    Sasaki R, Murakami M, Okamoto Y, et al. The efficacy of conventional radiation therapy in the management of pituitary adenoma. Int J Radiat Oncol Biol Phys 2000;47(5):1337–45.PubMedGoogle Scholar
  16. 16.
    Minniti G, Jaffrain-Rea M-L, Osti M, et al. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas. Clin Endocrinol 2005;62:210–6.CrossRefGoogle Scholar
  17. 17.
    Barkan AL, Halasz I, Dornfeld KJ, et al. Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. J Clin Endocrinol Metab 1997;82:3187–91.PubMedCrossRefGoogle Scholar
  18. 18.
    Ronson BB, Schulte RW, Han KP, et al. Fractionated proton beam irradiation of pituitary adenomas. Int J Radiat Oncol Biol Phys 2005;64(2):425–34.PubMedGoogle Scholar
  19. 19.
    Feigl GC, Bonelli CM, Berghold A, et al. Effects of gamma knife radiosurgery of pituitary adenomas on pituiary function. J Neurosurg 2002;97 Suppl 5:415–21.PubMedGoogle Scholar
  20. 20.
    Landolt AM, Haller D, Lomax N, et al. Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy. J Neurosurg 1998;88:1002–8.PubMedGoogle Scholar
  21. 21.
    Attanasio R, Epaminonda P, Motti E, et al. Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study. J Clin Endocrinol Metab 2003;88:3105–12.PubMedCrossRefGoogle Scholar
  22. 22.
    Littley MD, Shalet SM, Swindell R, et al. Low-dose pituitary irradiation for acromegaly. Clin Endocrinol (Oxf) 1990;32:261–70.Google Scholar
  23. 23.
    Pollock BE, Jacob JT, Brown PD, et al. Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission. J Neurosurg 2007;106:833–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Landolt AM, Haller D, Lomax N, et al. Octreotide may act as a radioprotective agent in acromegaly. J Clin Endocrinol Metab 2000;85:1287–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Vladyka V, Liscak R, Novotny J, et al. Radiation tolerance of functioning pituitary tissue in gamma knife surgery for pituitary adenomas. Neurosurgery 2003;52(2):309–17.PubMedCrossRefGoogle Scholar
  26. 26.
    Pai HH, Thornton A, Katznelson L, et al. Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose–effect relationship using dose–volume histogram analysis. Int J Radiat Oncol Biol Phys 2001;49(4):1079–92.PubMedCrossRefGoogle Scholar
  27. 27.
    Leber KA, Berglöff J, Pendl G. Dose–response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 1998;88:43–50.PubMedGoogle Scholar
  28. 28.
    Tishler RB, Loeffler JS, Lunsford LD, et al. Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int J Radiat Oncol Biol Phys 1993;27:215–21.PubMedGoogle Scholar
  29. 29.
    Brada M, Rajan B, Traish D, et al. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf) 1993;38:571–8.Google Scholar
  30. 30.
    Parsons JT, Bova FJ, Fitzgerald CR, et al. Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time–dose factors. Int J Radiat Oncol Biol Phys 1994;30(4):755–63.PubMedGoogle Scholar
  31. 31.
    McCord MW, Buatti JM, Fennell EM, et al. Radiotherapy for pituitary adenoma: long-term outcome and sequelae. Int J Radiat Oncol Biol Phys 1997;39(2):437–4.PubMedGoogle Scholar
  32. 32.
    Tsang RW, Laperriere NJ, Simpson WJ, et al. Glioma arising after radiation therapy for pituitary adenoma. Cancer 1993;72:2227–33.PubMedCrossRefGoogle Scholar
  33. 33.
    Pollock BE, Nippoldt TB, Stafford SL, et al. Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas: factors associated with endocrine normalization. J Neurosurg 2002;97:525–30.PubMedCrossRefGoogle Scholar
  34. 34.
    Izawa M, Hayashi M, Nakaya K, et al. Gamma knife radiosurgery for pituitary adenomas. J Neurosurg 2000;93 Suppl 3:19–22.PubMedGoogle Scholar
  35. 35.
    Brada M, Burchell L, Ashley S, et al. The incidence of cerebrovascular accidents in patients with pituitary adenoma. Int J Radiat Oncol Biol Phys 1999;45(3):693–8.PubMedGoogle Scholar
  36. 36.
    Lim YJ, Leem W, Park JT, et al. Cerebral infarction with ICA occlusion after gamma knife radiosurgery for pituitary adenoma: a case report. Stereotact Funct Neurosurg 1999;72 Suppl 1:132–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Ayuk J, Clayton RN, Holder G, et al. Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. J Clin Endocrinol Metab 2004;89(4):1613–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Department of Radiation OncologyMassachusetts General HospitalBostonUSA

Personalised recommendations